Physician profile
Laith Zamel
NPI 1336467844
$21,850.56
in general payments reported to CMS, 2019-2025
52 companies · $2,316 in 2025
The $2,316 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,681 · 2020: $3,182 · 2021: $5,061 · 2022: $3,169 · 2023: $2,836 · 2024: $2,606 · 2025: $2,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,758.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,465.17 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $2,706.51 | 2019-2025 | Wainua, Farxiga |
| Esperion Therapeutics, INC. | $1,750.47 | 2020-2025 | Nexletol, Nexlizet |
| Cardiovascular Systems INC. | $1,720.03 | 2019-2021 | |
| Abiomed | $1,463.03 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $1,126.61 | 2019-2025 | |
| Abbott Laboratories | $1,019.44 | 2019-2023 | Mitraclip |
| Biotronik INC. | $822.28 | 2022-2025 | Biomonitor, Acticor 7 Vr-T Dx |
| Janssen Pharmaceuticals, INC | $723.66 | 2019-2024 | Xarelto |
| Pfizer INC. | $629.14 | 2019-2025 | |
| Medtronic, INC. | $595.37 | 2022-2025 | Symplicity G3, Onyx Frontier, Hawkone |
| Amgen INC. | $578.04 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $532.68 | 2020-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $500.09 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $436.47 | 2019-2025 | Lifevest |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $374.59 | 2021-2023 | Barostim Neo System |
| Boston Scientific Corporation | $362.63 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Avvigo Guidance System, Varithena Administration Pack |
| Alnylam Pharmaceuticals INC. | $317.57 | 2024-2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $211.83 | 2019-2024 | |
| Novo Nordisk INC | $205.62 | 2019-2025 | Wegovy, Ozempic |
| Philips North America LLC | $176.02 | 2022-2024 | (5044) Mcot |
| Edwards Lifesciences Corporation | $162.87 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $150.50 | 2021-2024 | Verquvo |
| Irhythm Technologies, INC. | $141.95 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Akcea Therapeutics, INC. | $139.67 | 2019-2021 | |
| Medtronic Vascular, INC. | $128.97 | 2020 | |
| Arbor Pharmaceuticals, INC. | $128.94 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $117.10 | 2021-2023 | Arcalyst |
| Angiodynamics, INC. | $112.65 | 2020-2023 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Heartflow, INC. | $102.65 | 2024-2025 | |
| Chiesi USA, INC. | $87.85 | 2019-2025 | Kengreal |
| Saranas, INC. | $76.49 | 2022 | |
| Portola Pharmaceuticals, LLC | $74.79 | 2019-2020 | |
| Scpharmaceuticals INC. | $74.68 | 2024-2025 | |
| Amarin Pharma, INC. | $72.78 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $72.65 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $62.86 | 2024 | Arcalyst |
| W. L. Gore & Associates, INC. | $60.73 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $45.64 | 2023-2024 | Inpefa |
| Bard Peripheral Vascular, INC. | $43.32 | 2022 | |
| Atricure, INC. | $36.45 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $32.61 | 2022-2024 | Evkeeza |
| Terumo Medical Corporation | $29.22 | 2020 | |
| Teleflex LLC | $26.69 | 2019 | |
| Livanova USA, INC. | $26.21 | 2019 | |
| Azurity Pharmaceuticals, INC. | $20.52 | 2023 | Edarbi |
| Daxor Corporation | $20.42 | 2023 | Bva-100 |
| G Medical Diagnostic Services, INC. | $18.80 | 2019 | |
| Lilly USA, LLC | $18.75 | 2025 | Mounjaro |
| Lundbeck LLC | $18.30 | 2021 | |
| Cordis US Corp. | $18.12 | 2023 | Brite Tip Radianz |
| Acarix USA INC. | $10.13 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laith Zamel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.